- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03677765
Comparisons of Complications Related to Two Approaches of Ultrasonography-guided Subclavian Venous Catheterization
June 29, 2020 updated by: Hee-Pyoung Park, Seoul National University Hospital
A Prospective Non-inferiority Trial on Complications Related to Ultrasonography-guided Subclavian Venous Catheterization: Supraclavicular Versus Infraclavicular Approach
For performing subclavian venous catheterization, two approaches (supraclavicular and infraclavicular) have been used successfully in various clinical practice.
However, there remains controversy concerning which approach is safer and causes less complications during ultrasonography-guided subclavian venous catheterization.
In this context, the investigators sought to compare supraclavicular approach with infraclavicular approach in terms of post-procedural complications during ultrasonography-guided subclavian venous catheterization.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
416
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Seoul National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 77 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients who require subclavian venous catheterization
- adult patients aged 20-79
Exclusion Criteria:
- patient's refusal
- patients with contraindication of subclavian venous catheterization (skin infection at puncture site, tumor or thrombus in the course of subclavian vein, vegetation at tricuspid valve, patients on anticoagulation)
- patients with chemoport or pacemaker in subclavian vein
- patients with right-sided breast cancer operation or with right-sided pneumonectomy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Infraclavicular group
In the infraclavicular group, subclavian venous catheterization using ultrasonography is performed beneath the clavicle.
|
In the supraclavicular group, subclavian venous catheterization using ultrasonography is performed beneath the clavicle.
Meanwhile, in the infraclavicular group, subclavian venous catheterization using ultrasonography is performed over the clavicle.
|
Active Comparator: Supraclavicular group
In the supraclavicular group, subclavian venous catheterization using ultrasonography is performed over the clavicle.
|
In the supraclavicular group, subclavian venous catheterization using ultrasonography is performed beneath the clavicle.
Meanwhile, in the infraclavicular group, subclavian venous catheterization using ultrasonography is performed over the clavicle.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the overall incidence of complications
Time Frame: intraoperatively to 1 hour after the admission of ICU
|
The overall incidence of complications will be expressed as the sum of incidences of complications which occurred during subclavian venous catheterization including arterial puncture, hematoma formation, pneumothorax, hemothorax, and malposition of catheter.
Arterial puncture, hematoma formation, and malposition of catheter will be evaluated with ultrasonography, and pneumothorax and hemothorax will be evaluated by chest radiography.
|
intraoperatively to 1 hour after the admission of ICU
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the first-pass success rate
Time Frame: intraoperatively
|
The first-pass success was defined as successful catheterization on a single attempt in all stages of catheterization.
|
intraoperatively
|
the number of needling for venipuncture
Time Frame: intraoperatively
|
The number of needling for venipuncture was defined as the amount of needling for successful subclavian venous puncture.
|
intraoperatively
|
Total time for venipuncture
Time Frame: intraoperatively
|
Total time for venipuncture was defined as the amount of time which took for successful subclavian venous puncture.
|
intraoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 27, 2018
Primary Completion (Actual)
May 19, 2020
Study Completion (Actual)
May 19, 2020
Study Registration Dates
First Submitted
September 9, 2018
First Submitted That Met QC Criteria
September 17, 2018
First Posted (Actual)
September 19, 2018
Study Record Updates
Last Update Posted (Actual)
July 1, 2020
Last Update Submitted That Met QC Criteria
June 29, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- US_SVC: SC vs IC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Catheterization
-
Qilu Hospital of Shandong UniversityUnknownCatheterization, Peripheral | Catheterization, Central VenousChina
-
Wellspect HealthCareCompletedCatheterization (Clean, Intermittent Urinary Catheterization)Sweden
-
Becton, Dickinson and CompanyCompleted
-
3MUniversity of NebraskaCompletedCatheterization
-
University of PittsburghNational Institutes of Health (NIH)CompletedCatheterizationUnited States
-
University of PittsburghNational Institutes of Health (NIH)CompletedCatheterizationUnited States
-
Betul KartalIstanbul Medipol University HospitalRecruitingCatheter Complications | Catheter Related Complication | Urethral Catheterization | Urethral Catheterization Related InjuryTurkey
-
University of CalgaryRecruitingCatheterization, PeripheralCanada
Clinical Trials on Supra- vs Infraclavicular approach using ultrasonography
-
Centre hospitalier de l'Université de Montréal...RecruitingPostoperative Pain | Anesthesia, LocalCanada